Tufts CSDD shows multi-million dollar benefits of Translational Pharmaceutics

The outcomes from this research indicate that Translational Pharmaceutics can create substantial time savings and financial benefits to pharma and biotech companies

picture of

Breaking News

3i builds single-use bioprocessing platform using three acquisitions

The UK-based company has acquired Cellon, Silicone Altimex and TBL Performance Plastics to establish a platform serving ...

Genopis plans plasmid CDMO business launch

Helixmith US-based spinout has capitalised on its pDNA manufacturing experience with plans to launch a CDMO business

Porton Pharma Solutions opens new fermentation pilot lab in China

New fermentation capacity has enabled Porton to deliver kilogram level enzyme powder preparation to meet pilot-scale ...

Optimising viral vector production for biologics

To overcome existing challenges in viral vector production, Belgium-based Univercells has worked to develop an ...

Evotec agrees to give US Merck access to facility of the future

MSD has paid $15m to gain access to Just–Evotec Biologics’ J.POD Washington facility that conducts small, ...

Collaboration aims to commercialise regenerative medicine technology

Hitachi Chemical Advanced Therapeutics Solutions and Ori Biotech have agreed to work together to progress Ori’s ...

Medical cannabis made in Italy

Dr Fabio Di Francesco, a compounding pharmacist based in Rome, describes how cannabis is used in various dosage forms ...

NIBRT launches first online biopharma manufacturing programme

NIBRT Online Academy is online training that has been designed to assist with the skills and career development of ...

Eli Lilly makes $1.1bn biopharma acquisition

Pharma giant Eli Lilly has agreed to acquire chronic skin condition-focused biopharma Dermira

Lonza reveals process development roadmap for cell and gene therapies

Behnam Baghbaderani of Lonza Pharma & Biotech examines four manufacturing challenges inherent to the production of ...

Future market dynamics and opportunities in immuno-oncology

Long-term survival, tumour-agnostic effects and the potential for cure in a fraction of patients are key catalysts ...

Ditching pipettes for computers: The rise of artificial intelligence in biomanufacturing

Described as “the science and engineering of making intelligent machines,” AI (artificial intelligence) has ...

US gene therapy CDMO enters virus manufacturing partnership

Vigene Biosciences will provide manufacturing services for ASC for both early-stage and commercial virus production

Hospital moves in on manufacturing market

Nationwide Children’s Hospital has made competition for pharmaceutical companies by forming an affiliate company that ...